Investment Highlights
-
Discovers, Develops, and Commercialises novel anticancer and wound healing pharmaceuticals
-
Proven ability to partner successfully and commercialise products with global global industry leaders
-
Diverse and experienced team with over 20 years track record
Company Overview
-
Simultaneous human and veterinary development model
Delivers earlier returns and reduces risks for human development
-
Treating tumours & wounds with high-value, inter-related programmes
Human oncology & would healing pharmaceutical
-
Proprietary drug discovery platform EcoLogic™
Offer potential for long term growth targeting only the best biologically active molecules
-
Veterninary pharmaceuticals already in the market
Marketing veterinary drug STELFONTA in the US, Europe and Australia
QBiotics research and development program is based on compounds derived from the Australian tropical rainforest.
The product focus addresses unmet medical needs for humans and companion animals, with a concentration on the global health priority areas of cancer, specifically solid tumours, and chronic wound management.
QBiotics is an Australian life sciences company, inspired by nature to improve human and animal health.
Pursuing both monotherapy and combination therapy avenues in clinical trials to test efficacy and safety – results of these studies provided a clinically relevant and highly validated model for cancer in humans
Current Market Cap >A$500M
850,000 shares available
Team
- Management
- Directors
-
Dr Peter Schmidt
Chief Operating Officer
-
Michael Wenzel
Chief Financial Officer
-
Mary Phipps
Chief Marketing Officer
-
Dr Richard Yocum
Chief Medical Officer
-
Roberta Bozzili
Chief Legal & Commercial Officer
-
Ebru Davidson
General Counsel
-
Dr Tracey Mynott
Business Development Manager
-
Dr Sam Yurdakul
Director of Prduct Development
-
Rick Holliday-Smith AM
Non-Executive Chairman
-
Dr Victoria Gordon
Managing Director & CEO
-
Dr Paul Reddell
Executive Director & Chief Scientific Officer
-
Nicholas Moore
Non-Executive Director
-
Dr Susan Foden
Non-Executive Director
-
Andrew Denver
Non-Executive Director
-
Professor Bruce Robinson AC
Non-Executive Director
-
Associate Professor Steven Ogbourne
Non-Executive Director
-
Neville Mitchell
Non-Executive Director
-
Hamish Corlett
Non-Executive Director
Ask us a question
Ask Us a QuestionAlready a member?
Login nowBecome a member
Register now